Chao Han , Shijun Xiang , Renchao Zhang , Gang Cen, Yuan Fang, Zhengjun Qiu, Chen Huang
{"title":"Initial experience of single-incision robotic surgery for distal gastrectomy with da Vinci Xi platform","authors":"Chao Han , Shijun Xiang , Renchao Zhang , Gang Cen, Yuan Fang, Zhengjun Qiu, Chen Huang","doi":"10.1016/j.isurg.2023.02.001","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>The aim of this study was to describe technical considerations and short-term outcomes from the first reported single-incision robotic operation for distal gastrectomy with the use of da Vinci Xi surgical system.</p></div><div><h3>Methods</h3><p>A 71-year-old patient with a body-mass index of 22.4 kg/m<sup>2</sup> was treated for a gastrointestinal stromal tumor(GIST) in the posterior wall of the gastric antrum by single-incision robot-assisted distal gastrectomy with the da Vinci Xi robotic system on September 17, 2022 in Shanghai General Hospital.</p></div><div><h3>Results</h3><p>The single-incision da Vinci Xi robot-assisted distal gastrectomy was successfully performed with intraperitoneal Billroth Ⅱ anastomosis. The console time among the operation was 100 min with 10 ml of intraoperative blood loss. The patient was put on a liquid diet the next day after surgery and discharged on postoperative day 4. During the postoperative period, no severe adverse events occurred. The final pathology revealed a low-risk gastrointestinal stromal tumor (GIST) with a size of 5.0 × 3.5 × 2.5 cm.</p></div><div><h3>Conclusion</h3><p>Single-incision da Vinci Xi robot-assisted distal gastrectomy was a safe and feasible surgical method for patients with gastric tumor. The study filled in the corresponding research gaps and provided a basis for subsequent research. To verify its superior operative outcomes, further clinical trials are needed.</p></div>","PeriodicalId":100683,"journal":{"name":"Intelligent Surgery","volume":"6 ","pages":"Pages 12-15"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Intelligent Surgery","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666676623000029","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background
The aim of this study was to describe technical considerations and short-term outcomes from the first reported single-incision robotic operation for distal gastrectomy with the use of da Vinci Xi surgical system.
Methods
A 71-year-old patient with a body-mass index of 22.4 kg/m2 was treated for a gastrointestinal stromal tumor(GIST) in the posterior wall of the gastric antrum by single-incision robot-assisted distal gastrectomy with the da Vinci Xi robotic system on September 17, 2022 in Shanghai General Hospital.
Results
The single-incision da Vinci Xi robot-assisted distal gastrectomy was successfully performed with intraperitoneal Billroth Ⅱ anastomosis. The console time among the operation was 100 min with 10 ml of intraoperative blood loss. The patient was put on a liquid diet the next day after surgery and discharged on postoperative day 4. During the postoperative period, no severe adverse events occurred. The final pathology revealed a low-risk gastrointestinal stromal tumor (GIST) with a size of 5.0 × 3.5 × 2.5 cm.
Conclusion
Single-incision da Vinci Xi robot-assisted distal gastrectomy was a safe and feasible surgical method for patients with gastric tumor. The study filled in the corresponding research gaps and provided a basis for subsequent research. To verify its superior operative outcomes, further clinical trials are needed.